Archives by Month:

Archives by Year:

Best Buy Q1 Earnings & Revenues Beat Estimates

Best Buy Q1 Earnings & Revenues Beat Estimates

Best Buy Co., Inc. (BBY – Analyst Report), specialty retailer of consumer electronics, came out with first-quarter fiscal 2016 results, wherein adjusted earnings of 37 cents a share beat the Zacks Consensus Estimate of 29 cents, and increased 5.7% from the prior-year quarter. Renew Blue transformation program and strength seen in categories like large screen televisions and mobile […]
Ominous Stock Market Charts

Ominous Stock Market Charts

A Big Dow Theory Divergence We briefly want to show a few charts that have caught our eye recently. This is by no means a comprehensive market update (we plan to provide one soon). Here is something though one doesn’t see all too often: the Dow Industrials and Transportation averages have diverged from each other […]
UBS And JMP Securities Downgrade Achillion Pharmaceuticals, Inc. Following Johnson & Johnson Deal

UBS And JMP Securities Downgrade Achillion Pharmaceuticals, Inc. Following Johnson & Johnson Deal

Biotechnology company Achillion Pharmaceuticals (NASDAQ: ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its hepatitis C drug pipeline to Johnson & Johnson (NYSE: JNJ) for $1.1 billion. In the terms of the deal, Johnson & Johnson will pay Achillion Pharmaceuticals milestone payments totaling $1.1 billion throughout the development […]
Red Hot Shanghai Pushed Above Another Resistance Level

Red Hot Shanghai Pushed Above Another Resistance Level

When it comes to Red Hot stock markets the Shanghai index fits the bill. Below looks at the Year-To-Date performance of the Shanghai, DAX and S&P 500 indices. CLICK ON CHART TO ENLARGE As you can see the S&P 500 is lagging big time this year and even though the DAX is having a great […]
E
                                                
                        Value And Beyond: Why Stock Prices Are What They Are, Part 4

E Value And Beyond: Why Stock Prices Are What They Are, Part 4

<< Read Part 1: Why Stock Prices Are What They Are <<Read Part 2: From Dividends To EPS – Why Stock Prices Are What They Are <<Read Part 3: Out Of The Ivory Tower – Why Stock Prices Are What They Are This series discussing why stocks are priced as they are has traveled a log way. We […]
The Stock Whisper Of The Day: EEM, TSL

The Stock Whisper Of The Day: EEM, TSL

Morning Call For May 21, 2015

Morning Call For May 21, 2015

OVERNIGHT MARKETS AND NEWS June E-mini S&Ps (ESM15 -0.12%) this morning are down -0.21% ahead of economic data on U.S. Apr existing home sales and weekly jobless claims to gauge the timing of a Fed interest rate increase after Wednesday afternoon’s Apr 28-29 FOMC minutes reinforced the message that rates could rise at any Fed meeting. European stocks are […]
Pigs Break Out With Yields

Pigs Break Out With Yields

It is too early to call it a confirmed breakout, but the Bank index has popped above cyclical bull market highs. Weekly MACD and RSI both look good. The monthly chart shows that BKX has been consolidating above a long-term support area for the better part of 2 years. I had thought the BKX had […]
Is The Stock Market’s 5-Year Return A Useful Proxy For Valuation?

Is The Stock Market’s 5-Year Return A Useful Proxy For Valuation?

Tobin’s Q, a market-valuation metric, is back in the news, in part thanks to a widely read Bloomberg article. The story, published earlier this week, offered the provocative title: “Nobel Winner’s Math Is Showing S&P 500 Unhinged From Reality.” Oh, my, that sounds serious. Or maybe not. As several observers have pointed out (see here, here, and here, for instance), […]
Thursday’s Pre-Market Insights:BLUE, BBY, CRM, RIG

Thursday’s Pre-Market Insights:BLUE, BBY, CRM, RIG

bluebird bio. Inc. (NASDAQ:BLUE) ares increased  3.8% to $179 in pre-market trading after the company announced it will be presenting data on LentiGlobin, a pipeline product, at the 20th Congress of European Hematology Association on June 13. LentiGlobin is a therapy for a rare blood disorder, beta thalassemia. Best Buy Co., Inc. (NYSE:BBY) shares increased 10.12% […]